PCI The Journeys Within
Media Pack
News

Current Edition

JCS - Volume 18 Issue 3 - Autumn 2026
Frankfurt 2027 – 12/10/26
ramusmedical
Regional News

Vivalink Powers Translational Medicine Through Continuous Physiologic Monitoring Across Healthcare and Clinical Research

Research at Brigham and Women’s Hospital and Ochsner Health demonstrates how continuous physiologic data helps translate clinical research into more actionable patie...
27 October 2026 Regional News | Uncategorised
Continue Reading →
Current features

Pharmacovigilance Under Pressure: Why the Workflows Surrounding Case Management Can No Longer Be Left to Chance

The pharmaceutical industry has made considerable investments in digital safety infrastructure over the past two decades and the results in individual case managemen...
16 October 2026 Current features | Uncategorised
Continue Reading →
Uncategorised

CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development

CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a strategic partnership with Waters Corporation, a global leader in lif...
15 October 2026 Uncategorised
Continue Reading →
Regional News

CANCER RESEARCH UK AND NOVALGEN DOSE THE FIRST PATIENT IN THE PHASE 1 TRIAL OF T-CELL ENGAGER NVG-222

Cancer Research UK's Centre for Drug Development (CDD) and NovalGen today announce that the first patient has been dosed in a Phase 1 clinical trial evaluating NVG‑2...
16 March 2026 Regional News | Uncategorised
Continue Reading →
Regional News

Emmes Coordinates Groundbreaking Stem-Cell Ophthalmology Trial

 Emmes – a full-service, global Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation – in c...
26 February 2026 Regional News | Uncategorised
Continue Reading →
Current features

Artificial Intelligence and Ethical Review

As artificial intelligence (AI) becomes increasingly integrated into clinical research, Institutional Review Boards (IRBs) face new challenges in evaluating associat...
17 December 2025 Current features | Uncategorised
Continue Reading →
Current features

Communication is Key to Unlocking Clinical Trial Success

The importance of clear, consistent communication between contract research organisations (CRO), sponsors and trial sites cannot be stressed enough. Effective collab...
17 December 2025 Current features | Uncategorised
Continue Reading →
Current features

Embracing Quantitative Signal Detection Methods as a Smaller MAH

The major regulators have a minimum expectation that all pharma companies will be taking a proactive approach to real-world safety monitoring. As part of this, they ...
17 December 2025 Current features | Uncategorised
Continue Reading →
Current features

Overcoming Drug Distribution Hurdles in Hard-to-reach Clinical Trial Markets

Africa’s position in the global drug development landscape is transforming. Increasingly, sponsors are viewing the region through the lens of opportunity, especially...
17 December 2025 Current features | Uncategorised
Continue Reading →
Current features

Future of Blockchain Technology in Clinical Trials

Nowadays, when everything seems to be about artificial intelligence (AI), it is easy to forget that there are other technologies that will likely impact on how clini...
17 December 2025 Current features | Uncategorised
Continue Reading →
Quotient
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte